Article Listing - GW soars 51% on positive data from 3rd Ph III Sativex study; EU submission set for 2nd qtr

MOMENTUM OF 1991 CONTINUES AT SB

27 April 1992

The momentum achieved by Anglo-American pharmaceutical company SmithKline Beecham in 1991 is continuing in 1992, the company's results for the...

NAPP INTRODUCES REFORMULATED PARAMOL TO UK

27 April 1992

Napp Labs has introduced Paramol to the UK over-the-counter market. The new product represents a reformulated version of the original...

PFIZER NAMES VISINE AGENT

27 April 1992

Pfizer Inc has announced that it has chosen the New York advertising agency Partners and Shevack to handle its $10...

NEW J&J PREGNANCY TEST FOR UK

27 April 1992

A new one-step pregnancy test from Johnson & Johnson, the Fact Plus Pregnancy Testing Kit, has been launched onto the...

FORTHCOMING MEETINGS

27 April 1992

- Management Forum is organizing two round table meetings to be held in London: Schizophrenia: Recent Advances in Aetiology and...

MONGOLIAN DRUG PRICES RAISED

27 April 1992

Mongolia's Ministry of Health and Ministry of Industry have decided to increase the price of 165 imported medicines, reports the...

SHILEY FDA LETTER "UNNECESSARY"

27 April 1992

The Shiley Heart Valve Research Center has called "unnecessary" a letter issued by the Public Citizen Health Research Group that...

EARLY PROSTATE CANCER DIAGNOSIS AND THERAPY

27 April 1992

Radical treatments for untreated, early-stage prostate cancer should be considered experimental until further studies are carried out, according to a...

EASTERN EUROPEAN NEWS IN BRIEF

27 April 1992

- The Ministry of Trade and Industry of Bulgaria has stated that foreign pharmaceutical companies have expressed interest in establishing...

US FDA SLAMMED FOR "GUERILLA WAR" TACTICS

27 April 1992

We are now witnessing the emergence of a period of fundamentalist regulation and enforcement at the US Food and Drug...

Showing 94161-94170 of 95337 articles